CRP and type 2 diabetes mellitus: The adequately powered VITAL-study (n = 281) failed to show significant effects of paricalcitol on inflammatory biomarkers (CRP, fibrinogen, interleukin 6, TNF)in type 2 diabetes mellitus [25].